BRONCHIAL ASTHMA: EARLY CARDIOPULMONARY DYSFUNCTION

Authors

  • Lutfullaev O. O., Abdullayeva U.K., Muminova N. Kh., Jumayeva G. A., Rakhmatova M. R.. Bukhara State Medical Institute, Uzbekistan, Alfraganus University, Uzbekistan

DOI:

https://doi.org/10.55640/

Keywords:

Bronchial asthma; cardiopulmonary function; early functional disturbances; spirometry; electrocardiography; subclinical airway obstruction; cardiac dysrhythmia; hemodynamic load; individualized therapy; disease management

Abstract

Bronchial asthma (BA) is a chronic inflammatory disease of the airways, often associated with systemic manifestations affecting the cardiopulmonary system. The present study aimed to identify and evaluate early functional disturbances in the cardiopulmonary system of patients with BA. A cohort of patients with mild to moderate asthma underwent comprehensive assessments, including spirometry, electrocardiography, arterial blood pressure monitoring, and hemodynamic evaluation. Results revealed subclinical impairments in pulmonary ventilation, manifested by reductions in Forced Expiratory Volume in 1 second (FEV₁) and Peak Expiratory Flow (PEF), as well as early cardiac dysrhythmias and increased hemodynamic load. Correlation analyses demonstrated significant associations between disease duration, symptom severity, and functional alterations in both pulmonary and cardiac parameters. These findings underscore the systemic nature of BA, highlighting the importance of early detection, continuous monitoring, and individualized management strategies. Early interventions may prevent the progression of cardiopulmonary dysfunction, reduce the risk of complications, and improve overall patient outcomes. The study emphasizes the need for integrated cardiopulmonary evaluation in routine asthma care to optimize disease control and enhance quality of life.

Downloads

Download data is not yet available.

References

1.Belan, O. V. (2014). Cardiovascular comorbidities in patients with bronchial asthma. Russian Journal of Cardiology, 4(32), 45–52.

2.Greenberg, N. B. (2012). Systemic effects of chronic respiratory diseases. Journal of Pulmonology, 18(2), 101–108.

3.Ryabova, A. Yu. (2013). Interaction between metabolic syndrome and bronchial asthma. Clinical Medicine, 91(3), 27–34.

4.Solovyova, I. A. (2016). Early cardiopulmonary dysfunction in asthma patients. International Journal of Pulmonary Medicine, 12(1), 15–22.

5.Yakovleva, O. A. (2016). Autonomic nervous system involvement in obstructive pulmonary disease. Cardiopulmonary Research, 8(4), 56–63.

6.Bubnova, M. G. (2014). Pathophysiological mechanisms linking asthma and cardiovascular disease. Russian Journal of Clinical Medicine, 21(5), 42–49.

7.Vasilieva, T. S. (2013). Metabolic and cardiovascular comorbidities in bronchial asthma. Clinical Research in Pulmonology, 7(2), 34–40.

8.Pashkova, O. (2011). The role of the autonomic nervous system in bronchial obstruction. Journal of Pulmonary Pathophysiology, 3(1), 22–28.

9.Global Initiative for Asthma (GINA). (2024). Global Strategy for Asthma Management and Prevention (2024 update). Available from https://ginasthma.org/2024report/ Global Initiative for Asthma - GINA+2imsear.searo.who.int+2

10.Rajvanshi, N., Kumar, P., & Goyal, J. P. (2024). Global Initiative for Asthma Guidelines 2024: An Update. Indian Pediatrics, 61(8), 781786. imsear.searo.who.int

11.“How are asthma and heart health linked?” (2024, May 17). American Heart Association News. Available from https://www.heart.org/en/news/2024/05/17/how-are-asthma-and-heart-health-linked www.heart.org

12.Zhang, M., Guo, X., Guo, W., et al. (2025). “Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?” BMC Pulmonary Medicine, 25, 348.

Downloads

Published

2025-11-11

How to Cite

BRONCHIAL ASTHMA: EARLY CARDIOPULMONARY DYSFUNCTION. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(10), 541-544. https://doi.org/10.55640/

Similar Articles

1-10 of 1967

You may also start an advanced similarity search for this article.